Dr Reddy’s Laboratories (NYSE:RDY) reported its Q3 earnings results on Tuesday, January 30, 2024 at 01:30 PM.
Here’s what investors need to know about the announcement.
Earnings
Dr Reddy’s Laboratories beat estimated earnings by 25.32%, reporting an EPS of $0.99 versus an estimate of $0.79.
Revenue was up $42.39 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.23 which was followed by a 0.7% increase in the share price the next day.
Here’s a look at Dr Reddy’s Laboratories’s past performance:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | 0.84 | 0.70 | 0.64 | 0.58 |
| EPS Actual | 1.07 | 1.03 | 0.70 | 0.91 |
| Revenue Estimate | 819.33M | 783.68M | 742.18M | 699.00M |
| Revenue Actual | 828.00M | 821.00M | 766.00M | 824.61M |
To track all earnings releases for Dr Reddy’s Laboratories visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
